Vopratelimab

Vopratelimab Uses, Dosage, Side Effects, Food Interaction and all others data.

Vopratelimab is under investigation in clinical trial NCT02904226 (JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors).

Trade Name Vopratelimab
Generic Vopratelimab
Vopratelimab Other Names Vopratelimab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Vopratelimab
Vopratelimab

Innovators Monograph

You find simplified version here Vopratelimab


*** Taking medicines without doctor's advice can cause long-term problems.
Share